Literature DB >> 24383089

Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

David J Schretlen, Mark Varvaris, Tiffany E Ho, Tracy D Vannorsdall, Barry Gordon, James C Harris, H A Jinnah.   

Abstract

BACKGROUND: Lesch-Nyhan disease is a rare, X-linked, neurodevelopmental metabolic disorder that is caused by abnormalities in the levels of hypoxanthine-guanine phosphoribosyltransferase enzyme activity. The neural substrates associated with Lesch-Nyhan disease remain poorly understood. We aimed to use voxel-based morphometry to identify affected brain regions in classic Lesch-Nyhan disease and Lesch-Nyhan variant disease, and to identify regions that differ between the two disease types.
METHODS: In this cross-sectional study, we recruited patients with classic Lesch-Nyhan disease or Lesch-Nyhan variant disease from clinics, referrals, the Lesch-Nyhan Syndrome Registry, and the Matheny School and Hospital (Peapack, NJ, USA), and healthy controls from the Baltimore metropolitan area (MD, USA). We used voxel-based morphometry to analyse grey matter volume between groups using a three-group ANCOVA, followed by six pairwise post-hoc group comparisons.
FINDINGS: Between Oct 3, 1993, and April 29, 2013, we recruited 21 patients with classic Lesch-Nyhan disease, 17 patients with variant disease, and 33 healthy controls. Patients with classic Lesch-Nyhan disease had a 20% reduction in intracranial volume (17% reduction in grey matter volume; 26% reduction in white matter volume) compared with healthy adults. The largest differences were in basal ganglia, and frontotemporal and limbic regions, with sparing of parieto-occipital regions. Grey matter volumes of patients with Lesch-Nyhan variant disease were invariably between those of patients with classic Lesch-Nyhan disease and healthy controls. Compared with healthy controls, patients with classic disease showed additional grey matter volume reductions in the temporal lobe and left lateralised structures, and patients with variant disease showed additional reductions in lingual and precuneus regions with sparing of right frontal and temporal regions. Patients with classic disease had reductions of volume in the ventral striatum and prefrontal areas compared with those with the variant form.
INTERPRETATION: We noted regional abnormalities associated with known neurological and behavioural deficits in patients with classic Lesch-Nyhan disease. Patients with Lesch-Nyhan variant disease show milder grey matter abnormalities in many of the same brain regions and preservation of grey matter volume in other regions, which could provide important clues to the neural substrates of differences between the phenotypes. FUNDING: National Institute of Child Health and Human Development, Therapeutic Cognitive Neuroscience Fund, and Benjamin and Adith Miller Family Endowment on Aging, Alzheimer's and Autism Research.

Entities:  

Mesh:

Year:  2013        PMID: 24383089      PMCID: PMC3932536          DOI: 10.1016/s1474-4422(13)70238-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  31 in total

1.  Lesch-Nyhan syndrome in a girl.

Authors:  P van Bogaert; I Ceballos; I Desguerre; L Telvi; P Kamoun; G Ponsot
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Lesch-Nyhan syndrome with delayed onset of self-mutilation: hyperactivity of interneurons at the brainstem and blink reflex.

Authors:  T Hatanaka; H Higashino; M Woo; A Yasuhara; T Sugimoto; Y Kobayashi
Journal:  Acta Neurol Scand       Date:  1990-02       Impact factor: 3.209

3.  Lesch-Nyhan syndrome: report of two cases.

Authors:  R A Salman; R S Glickman; S Super
Journal:  J Oral Med       Date:  1987 Jan-Mar

4.  [Cranial computerized tomography in incomplete Lesch-Nyhan syndrome].

Authors:  M Holdeigel
Journal:  Radiologe       Date:  1987-03       Impact factor: 0.635

5.  A female case of the Leach-Nyhan syndrome.

Authors:  K Hara; S Kashiwamata; N Ogasawara; H Ohishi; R Natsume; T Yamanaka; S Hakamada; S Miyazaki; K Watanabe
Journal:  Tohoku J Exp Med       Date:  1982-07       Impact factor: 1.848

6.  Recurrent coma and Lesch-Nyhan syndrome.

Authors:  B J Lynch; M J Noetzel
Journal:  Pediatr Neurol       Date:  1991 Sep-Oct       Impact factor: 3.372

Review 7.  The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome.

Authors:  A A Baumeister; G D Frye
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

8.  Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters.

Authors:  J Jankovic; T C Caskey; J T Stout; I J Butler
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

9.  Validity and reliability of a rating scale for the primary torsion dystonias.

Authors:  R E Burke; S Fahn; C D Marsden; S B Bressman; C Moskowitz; J Friedman
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

10.  Lesch-Nyhan syndrome: biochemical characterization of a case with attenuated behavioral manifestation.

Authors:  A Fattal; Z Spirer; E Zoref-Shani; O Sperling
Journal:  Enzyme       Date:  1984
View more
  14 in total

1.  Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling?

Authors:  David J Schretlen; Wynne Callon; Rebecca E Ward; Rong Fu; Tiffany Ho; Barry Gordon; James C Harris; H A Jinnah
Journal:  J Inherit Metab Dis       Date:  2015-06-12       Impact factor: 4.982

2.  Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan disease pathogenesis.

Authors:  R J Torres; J G Puig
Journal:  J Inherit Metab Dis       Date:  2015-05-05       Impact factor: 4.982

3.  Rescuing compounds for Lesch-Nyhan disease identified using stem cell-based phenotypic screening.

Authors:  Valentin Ruillier; Johana Tournois; Claire Boissart; Marie Lasbareilles; Gurvan Mahé; Laure Chatrousse; Michel Cailleret; Marc Peschanski; Alexandra Benchoua
Journal:  JCI Insight       Date:  2020-02-27

4.  Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants.

Authors:  David J Schretlen; Mark Varvaris; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Neurology       Date:  2014-12-10       Impact factor: 9.910

Review 5.  Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.

Authors:  Khue Vu Nguyen
Journal:  AIMS Neurosci       Date:  2022-04-21

6.  HGprt deficiency disrupts dopaminergic circuit development in a genetic mouse model of Lesch-Nyhan disease.

Authors:  J E Visser; S M Kolk; J S Witteveen; S R Loopstok; L Luque Ballesteros; A Boonstra; N H M van Bakel; W H P van Boekel; G J M Martens
Journal:  Cell Mol Life Sci       Date:  2022-06-04       Impact factor: 9.207

7.  Microstructural white matter abnormalities in Lesch-Nyhan disease.

Authors:  Victor A Del Bene; Jeffrey L Crawford; Ainara Gómez-Gastiasoro; Tracy D Vannorsdall; Alison Buchholz; Natalia Ojeda; James C Harris; Hyder A Jinnah; David J Schretlen
Journal:  Eur J Neurosci       Date:  2021-12-06       Impact factor: 3.698

Review 8.  Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.

Authors:  Rong Fu; Chung-Jen Chen; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-05-28       Impact factor: 4.797

Review 9.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

10.  Loss of dopamine phenotype among midbrain neurons in Lesch-Nyhan disease.

Authors:  Martin Göttle; Cecilia N Prudente; Rong Fu; Diane Sutcliffe; Hong Pang; Deborah Cooper; Emir Veledar; Jonathan D Glass; Marla Gearing; Jasper E Visser; H A Jinnah
Journal:  Ann Neurol       Date:  2014-06-20       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.